A study of pyrazolo-benzimidazole derivatives as spleen tyrosine kinase inhibitors: an in-silico approach

2018 ◽  
Vol 30 (1) ◽  
pp. 263-272 ◽  
Author(s):  
Sonal Dubey ◽  
P. Prabitha ◽  
Sakshi Bhardwaj ◽  
Ekta Singh
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
In Silico ◽  
Kinase Inhibitors ◽  
Benzimidazole Derivatives ◽  
Spleen Tyrosine Kinase

Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors

2016 ◽  
Vol 13 (9) ◽  
pp. 845-858
Author(s):  
Letícia Cristina Assis ◽  
Letícia Santos Garcia ◽  
Daiana Teixeira Mancini ◽  
Tamiris Maria Assis ◽  
Daniela Rodrigues Silva ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Spleen Tyrosine Kinase ◽  
Design Studies

Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening

2008 ◽  
Vol 18 (1) ◽  
pp. 285-288 ◽  
Author(s):  
Taikou Usui ◽  
Hyun Seung Ban ◽  
Junpei Kawada ◽  
Takatsugu Hirokawa ◽  
Hiroyuki Nakamura
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
High Throughput ◽  
In Silico ◽  
High Throughput Screening ◽  
Kinase Inhibitors

In vitro and in silico evaluation of EGFR targeting activities of curcumin and its derivatives

2021 ◽  
Author(s):  
Yuan Liang ◽  
Jingqi Zhao ◽  
Haoyang Zou ◽  
Jie Zhang ◽  
Tiehua Zhang
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
In Silico ◽  
Kinase Inhibitors

Curcumin and its derivatives are potential tyrosine kinase inhibitors that target EGFR.

Using Ovality to Predict Nonmutagenic, Orally Efficacious Pyridazine Amides as Cell Specific Spleen Tyrosine Kinase Inhibitors

2014 ◽  
Vol 57 (6) ◽  
pp. 2683-2691 ◽  
Author(s):  
Matthew C. Lucas ◽  
Niala Bhagirath ◽  
Eric Chiao ◽  
David M. Goldstein ◽  
Johannes C. Hermann ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors ◽  
Spleen Tyrosine Kinase
Sign in / Sign up

Export Citation Format

Share Document